Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3220 results found

2025 ∙ Jiao, X. Zhu, J. Ding, Y. Xiao, M. Zhai, Z.

Effect of herpes zoster vaccine on patients after hematopoietic stem cell transplantation: a systematic review and meta-analysis

  • All age groups
  • Herpes zoster
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Peng, R. Zhang, T. Dunne, E. M. Xu, Z. Sun, A. Cheng, J. Yang, J. Zhao, G.

Effectiveness and impact of 7 and 13-valent pneumococcal conjugate vaccines in Chinese children: A systematic review and meta-analysis

  • Western Pacific
  • China
  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Dunne, E. M. Hong, L. Althouse, B. M. Hayford, K. Jodar, L. Gessner, B. D. Theilacker, C.

Effectiveness of a Single Dose of Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Children: A Systematic Literature Review

  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Phiri, W. W. Kazonga, E. Lubemba, F. Kangwa, G. M. Sakala, L. Banda, M.

Effectiveness of Community-Based Interventions in Reducing Vaccine Hesitancy and Improving COVID-19 Vaccinations Coverage in Developing Countries: A Systematic Review

  • Adults
  • Older adults
  • Low and Middle Income Countries
  • COVID-19
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Peine, C. Stoliaroff-Pepin, A. Reinacher, U. Heldt, K. Sarganas, G. Piechotta, V. Mikolajewska, A. Pilic, A. Barkowski, N. Bleve, D. Giebeler, M. H. Poser, S. Searle, L. Kissner, E. Nitsche, L. Bayram, F. Siemens, W. Ziegler, A. Meerpohl, J. J. Sandmann, F. Wichmann, O. Harder, T.

Effectiveness of COVID-19 vaccines against post-COVID-19 condition/long COVID: systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
High
2025 ∙ Zhou, G. Dael, N. Verweij, S. Balafas, S. Mubarik, S. Rengerink, K. O. Pasmooij, A. M. G. van Baarle, D. Mol, P. G. M. de Bock, G. H. Hak, E.

Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024

  • Europe
  • Adolescents
  • Adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Alqahtani, M. S. Hamed, N. F. Alhowity, E. Alomogren, F. A. Alkhaldi, D. M. Alanazi, F. K. M. Kaddoura, A.

Effectiveness of Influenza Vaccination against Influenza-related Hospitalizations among Children: A Systematic Review

  • Newborn
  • Children
  • Adolescents
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ S, A. K. Wasnik, A. Gupta, L. Ranjan, A. Suresh, H.

Effectiveness of interventions to improve vaccine efficacy: a systematic review and meta-analysis

  • All age groups
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Bulkhi, A. Khadawardi, H. A. Dairi, M. S. Alwafi, H. Alim, H. M. Turkistani, Y. A. Almoallim, H. M. Alghamdi, I. A. Alqashqri, H. S. Obaid, M. S. Alkhotani, A. M. A. Alhazmi, A. S. H. Adly, H. M. Zaini, R. Abdulkhaliq, A. A. Saleh, S. A. K. Hariri, N. H. Khan, A. A. Alamri, F. A. Garout, M. A.

Effectiveness of pneumococcal vaccination in reducing hospitalization and mortality among the elderly: A systematic review and meta-analysis

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Chen, S. Wang, S. Cheung, D. H. Fang, Y. Sun, F. Mo, P. K. H. Wang, Z.

Effectiveness of stage-of-change (SOC)-tailored interventions in increasing uptake of any type of vaccination: A systematic review and meta-analysis

  • All age groups
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
Loading...